• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, May 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Leading cancer research team win the 2018 European Health Award

Bioengineer by Bioengineer
October 3, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
AUDIO

Credit: Queen's University Belfast

Researchers from Queen's University Belfast and the University of Leeds, as part of a pan-European partnership called the European Cancer Concord (ECC) ®, have won the prestigious 2018 European Health Award.

This award honours initiatives that help tackle some of Europe's most pressing health challenges.

The award-winning project, entitled 'The European Cancer Patient's Bill of Rights: A Catalyst for Change and an empowerment tool for cancer patients across Europe' involves an equal partnership between cancer patients, healthcare professionals and cancer researchers.

Professor Mark Lawler, Chair in Translational Cancer Research at Queen's University Belfast and Vice President of ECC, today (Wednesday 3 October) received the award on behalf of the partnership during the opening ceremony of the European Health Forum Gastein, the premier European Health Policy Conference and an official event of the Austrian European Council Presidency.

One of the key outputs from the research has been the development of a 70:35 Vision, 70 per cent long term survival for all cancer patients across Europe by 2035.

"Our 70:35 Vision is built upon the pillars of cross border and interdisciplinary cooperation, sharing best practice and ensuring that research and innovation gets translated for the benefit of patients," explained Professor Peter Selby, Professor of Cancer Medicine at the University of Leeds and President of ECC. "This is a superb example of how cooperative European activities that involve sharing best practice between countries can result in top class prize-winning initiatives."

Professor Lawler commented: "Cancer knows no borders, so it is important that we work together to develop solutions that address cancer inequalities in all parts of Europe. I am immensely proud to be accepting this award, not only on behalf of our team who have worked together over the last five years on this initiative, but also on behalf of the millions of European citizens who are living with and beyond cancer, and experiencing cancer inequalities every single day of their lives."

Margaret Grayson, cancer survivor and Chairperson of the Northern Ireland Cancer Research Consumer Forum, said: "The news that the European Cancer Patient's Bill of Rights has received a top European award is wonderful. This collaborative initiative has patients absolutely at its centre. It is especially pleasing that Professor Lawler will be collecting this award at Gastein, given Northern Ireland's leadership role in the project."

In a joint statement, Professor Ian Greer, President and Vice-Chancellor of Queen's University Belfast and Professor Sir Alan Langlands, Vice-Chancellor of the University of Leeds welcomed the award: "The European Health Award is a prestigious award that recognises the very best of the European collaborative approach, involving over 60 stakeholders from 25 European countries, working together for the benefit of patients.

"We are immensely proud that an initiative, which was initiated at Queen's University in Northern Ireland, and where Leeds University and Queen's have demonstrated their strong leadership, has been recognised across Europe as a quality exemplar of best practice."

Working in close partnership with European patient organisations and professional societies has been a key part of the initiative.

"We at the European Cancer Patient Coalition (ECPC) are delighted to be part of this joint success," Lydia Makaroff, Director of the European Cancer Patient Coalition, added. "The ECPC has been a crucial partner in the European Cancer Patient's Bill of Rights since it was launched in the European Parliament on Word Cancer Day in 2014, and has worked tirelessly to find solutions to the disparities that cancer patients experience across Europe."

Speaking at the award ceremony, Professor Lawler said: "Cooperation is the key to this initiative. We need to compete, not against each other, but against our common enemy – Cancer."

###

Media inquiries to Zara McBrearty at Queen's University Communications Office on +44 (0)28 9097 2642/Mob: 07795676858 or [email protected].

Media Contact

Zara McBrearty
[email protected]
44-289-097-3259
@QUBelfast

http://www.qub.ac.uk

Share12Tweet7Share2ShareShareShare1

Related Posts

Impact of Immigration Restrictions on the US Healthcare Workforce

May 31, 2026

Innovative AI Technique Predicts Radiation Dosage Prior to Treatment in Advanced Prostate Cancer

May 31, 2026

COXFA4L2 Boosts Cytochrome C Oxidase in Leigh Syndrome

May 31, 2026

Precise Gene Control Using FDA-Approved RNA Splicing Drug

May 30, 2026
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    319 shares
    Share 128 Tweet 80
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    81 shares
    Share 32 Tweet 20
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    56 shares
    Share 22 Tweet 14
  • AI-Powered Atlas Uncovers Extensive Whole-Body Damage Linked to Obesity

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Impact of Immigration Restrictions on the US Healthcare Workforce

Study Reveals Cancer Diagnostic Delays Linked to Population-Based Screening Using Cell-Free DNA Multicancer Early Detection Test

Innovative AI Technique Predicts Radiation Dosage Prior to Treatment in Advanced Prostate Cancer

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.